nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Intestinal obstruction—Thiotepa—sarcoma	0.0411	0.0411	CcSEcCtD
Sevelamer—Ileus—Thiotepa—sarcoma	0.0396	0.0396	CcSEcCtD
Sevelamer—Faecaloma—Epirubicin—sarcoma	0.0395	0.0395	CcSEcCtD
Sevelamer—Faecalith—Epirubicin—sarcoma	0.0395	0.0395	CcSEcCtD
Sevelamer—Faecaloma—Doxorubicin—sarcoma	0.0365	0.0365	CcSEcCtD
Sevelamer—Faecalith—Doxorubicin—sarcoma	0.0365	0.0365	CcSEcCtD
Sevelamer—Intestinal obstruction—Vincristine—sarcoma	0.0365	0.0365	CcSEcCtD
Sevelamer—Ileus—Vincristine—sarcoma	0.0351	0.0351	CcSEcCtD
Sevelamer—Ileus—Epirubicin—sarcoma	0.0159	0.0159	CcSEcCtD
Sevelamer—Ileus—Doxorubicin—sarcoma	0.0147	0.0147	CcSEcCtD
Sevelamer—Arthralgia—Thiotepa—sarcoma	0.0104	0.0104	CcSEcCtD
Sevelamer—Anorexia—Thiotepa—sarcoma	0.00953	0.00953	CcSEcCtD
Sevelamer—Anorexia—Dactinomycin—sarcoma	0.00946	0.00946	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00911	0.00911	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00904	0.00904	CcSEcCtD
Sevelamer—Arthralgia—Mitoxantrone—sarcoma	0.00901	0.00901	CcSEcCtD
Sevelamer—Dyspepsia—Thiotepa—sarcoma	0.0088	0.0088	CcSEcCtD
Sevelamer—Decreased appetite—Thiotepa—sarcoma	0.00869	0.00869	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Thiotepa—sarcoma	0.00863	0.00863	CcSEcCtD
Sevelamer—Decreased appetite—Dactinomycin—sarcoma	0.00863	0.00863	CcSEcCtD
Sevelamer—Fatigue—Thiotepa—sarcoma	0.00862	0.00862	CcSEcCtD
Sevelamer—Fatigue—Dactinomycin—sarcoma	0.00855	0.00855	CcSEcCtD
Sevelamer—Pain—Thiotepa—sarcoma	0.00855	0.00855	CcSEcCtD
Sevelamer—Constipation—Thiotepa—sarcoma	0.00855	0.00855	CcSEcCtD
Sevelamer—Pain—Dactinomycin—sarcoma	0.00849	0.00849	CcSEcCtD
Sevelamer—Anorexia—Vincristine—sarcoma	0.00845	0.00845	CcSEcCtD
Sevelamer—Anorexia—Mitoxantrone—sarcoma	0.00823	0.00823	CcSEcCtD
Sevelamer—Gastrointestinal pain—Thiotepa—sarcoma	0.00818	0.00818	CcSEcCtD
Sevelamer—Gastrointestinal pain—Dactinomycin—sarcoma	0.00811	0.00811	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Vincristine—sarcoma	0.00808	0.00808	CcSEcCtD
Sevelamer—Abdominal pain—Thiotepa—sarcoma	0.0079	0.0079	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00787	0.00787	CcSEcCtD
Sevelamer—Abdominal pain—Dactinomycin—sarcoma	0.00784	0.00784	CcSEcCtD
Sevelamer—Decreased appetite—Vincristine—sarcoma	0.00771	0.00771	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Vincristine—sarcoma	0.00765	0.00765	CcSEcCtD
Sevelamer—Fatigue—Vincristine—sarcoma	0.00764	0.00764	CcSEcCtD
Sevelamer—Dyspepsia—Mitoxantrone—sarcoma	0.0076	0.0076	CcSEcCtD
Sevelamer—Pain—Vincristine—sarcoma	0.00758	0.00758	CcSEcCtD
Sevelamer—Constipation—Vincristine—sarcoma	0.00758	0.00758	CcSEcCtD
Sevelamer—Decreased appetite—Mitoxantrone—sarcoma	0.00751	0.00751	CcSEcCtD
Sevelamer—Fatigue—Mitoxantrone—sarcoma	0.00744	0.00744	CcSEcCtD
Sevelamer—Pain—Mitoxantrone—sarcoma	0.00738	0.00738	CcSEcCtD
Sevelamer—Constipation—Mitoxantrone—sarcoma	0.00738	0.00738	CcSEcCtD
Sevelamer—Gastrointestinal pain—Vincristine—sarcoma	0.00725	0.00725	CcSEcCtD
Sevelamer—Asthenia—Thiotepa—sarcoma	0.00717	0.00717	CcSEcCtD
Sevelamer—Abdominal distension—Epirubicin—sarcoma	0.00713	0.00713	CcSEcCtD
Sevelamer—Asthenia—Dactinomycin—sarcoma	0.00712	0.00712	CcSEcCtD
Sevelamer—Pruritus—Thiotepa—sarcoma	0.00707	0.00707	CcSEcCtD
Sevelamer—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00706	0.00706	CcSEcCtD
Sevelamer—Abdominal pain—Vincristine—sarcoma	0.00701	0.00701	CcSEcCtD
Sevelamer—Anorexia—Etoposide—sarcoma	0.00685	0.00685	CcSEcCtD
Sevelamer—Diarrhoea—Thiotepa—sarcoma	0.00684	0.00684	CcSEcCtD
Sevelamer—Abdominal pain—Mitoxantrone—sarcoma	0.00682	0.00682	CcSEcCtD
Sevelamer—Diarrhoea—Dactinomycin—sarcoma	0.00679	0.00679	CcSEcCtD
Sevelamer—Abdominal distension—Doxorubicin—sarcoma	0.00659	0.00659	CcSEcCtD
Sevelamer—Asthenia—Vincristine—sarcoma	0.00636	0.00636	CcSEcCtD
Sevelamer—Vomiting—Thiotepa—sarcoma	0.00636	0.00636	CcSEcCtD
Sevelamer—Vomiting—Dactinomycin—sarcoma	0.00631	0.00631	CcSEcCtD
Sevelamer—Rash—Thiotepa—sarcoma	0.0063	0.0063	CcSEcCtD
Sevelamer—Dermatitis—Thiotepa—sarcoma	0.0063	0.0063	CcSEcCtD
Sevelamer—Rash—Dactinomycin—sarcoma	0.00626	0.00626	CcSEcCtD
Sevelamer—Decreased appetite—Etoposide—sarcoma	0.00624	0.00624	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Etoposide—sarcoma	0.0062	0.0062	CcSEcCtD
Sevelamer—Asthenia—Mitoxantrone—sarcoma	0.00619	0.00619	CcSEcCtD
Sevelamer—Fatigue—Etoposide—sarcoma	0.00619	0.00619	CcSEcCtD
Sevelamer—Pain—Etoposide—sarcoma	0.00614	0.00614	CcSEcCtD
Sevelamer—Constipation—Etoposide—sarcoma	0.00614	0.00614	CcSEcCtD
Sevelamer—Diarrhoea—Vincristine—sarcoma	0.00607	0.00607	CcSEcCtD
Sevelamer—Nausea—Thiotepa—sarcoma	0.00594	0.00594	CcSEcCtD
Sevelamer—Diarrhoea—Mitoxantrone—sarcoma	0.00591	0.00591	CcSEcCtD
Sevelamer—Nausea—Dactinomycin—sarcoma	0.00589	0.00589	CcSEcCtD
Sevelamer—Gastrointestinal pain—Etoposide—sarcoma	0.00587	0.00587	CcSEcCtD
Sevelamer—Abdominal pain—Etoposide—sarcoma	0.00568	0.00568	CcSEcCtD
Sevelamer—Vomiting—Vincristine—sarcoma	0.00564	0.00564	CcSEcCtD
Sevelamer—Rash—Vincristine—sarcoma	0.00559	0.00559	CcSEcCtD
Sevelamer—Dermatitis—Vincristine—sarcoma	0.00558	0.00558	CcSEcCtD
Sevelamer—Vomiting—Mitoxantrone—sarcoma	0.00549	0.00549	CcSEcCtD
Sevelamer—Rash—Mitoxantrone—sarcoma	0.00544	0.00544	CcSEcCtD
Sevelamer—Dermatitis—Mitoxantrone—sarcoma	0.00544	0.00544	CcSEcCtD
Sevelamer—Nausea—Vincristine—sarcoma	0.00527	0.00527	CcSEcCtD
Sevelamer—Asthenia—Etoposide—sarcoma	0.00515	0.00515	CcSEcCtD
Sevelamer—Nausea—Mitoxantrone—sarcoma	0.00513	0.00513	CcSEcCtD
Sevelamer—Pruritus—Etoposide—sarcoma	0.00508	0.00508	CcSEcCtD
Sevelamer—Diarrhoea—Etoposide—sarcoma	0.00491	0.00491	CcSEcCtD
Sevelamer—Flatulence—Epirubicin—sarcoma	0.00486	0.00486	CcSEcCtD
Sevelamer—Vomiting—Etoposide—sarcoma	0.00457	0.00457	CcSEcCtD
Sevelamer—Rash—Etoposide—sarcoma	0.00453	0.00453	CcSEcCtD
Sevelamer—Dermatitis—Etoposide—sarcoma	0.00452	0.00452	CcSEcCtD
Sevelamer—Flatulence—Doxorubicin—sarcoma	0.0045	0.0045	CcSEcCtD
Sevelamer—Nausea—Etoposide—sarcoma	0.00427	0.00427	CcSEcCtD
Sevelamer—Arthralgia—Epirubicin—sarcoma	0.0042	0.0042	CcSEcCtD
Sevelamer—Arthralgia—Doxorubicin—sarcoma	0.00389	0.00389	CcSEcCtD
Sevelamer—Anorexia—Epirubicin—sarcoma	0.00384	0.00384	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00367	0.00367	CcSEcCtD
Sevelamer—Anorexia—Doxorubicin—sarcoma	0.00355	0.00355	CcSEcCtD
Sevelamer—Dyspepsia—Epirubicin—sarcoma	0.00354	0.00354	CcSEcCtD
Sevelamer—Decreased appetite—Epirubicin—sarcoma	0.0035	0.0035	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Epirubicin—sarcoma	0.00348	0.00348	CcSEcCtD
Sevelamer—Fatigue—Epirubicin—sarcoma	0.00347	0.00347	CcSEcCtD
Sevelamer—Pain—Epirubicin—sarcoma	0.00344	0.00344	CcSEcCtD
Sevelamer—Constipation—Epirubicin—sarcoma	0.00344	0.00344	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00339	0.00339	CcSEcCtD
Sevelamer—Gastrointestinal pain—Epirubicin—sarcoma	0.00329	0.00329	CcSEcCtD
Sevelamer—Dyspepsia—Doxorubicin—sarcoma	0.00328	0.00328	CcSEcCtD
Sevelamer—Decreased appetite—Doxorubicin—sarcoma	0.00324	0.00324	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00322	0.00322	CcSEcCtD
Sevelamer—Fatigue—Doxorubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Sevelamer—Constipation—Doxorubicin—sarcoma	0.00319	0.00319	CcSEcCtD
Sevelamer—Pain—Doxorubicin—sarcoma	0.00319	0.00319	CcSEcCtD
Sevelamer—Abdominal pain—Epirubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Sevelamer—Gastrointestinal pain—Doxorubicin—sarcoma	0.00305	0.00305	CcSEcCtD
Sevelamer—Abdominal pain—Doxorubicin—sarcoma	0.00294	0.00294	CcSEcCtD
Sevelamer—Asthenia—Epirubicin—sarcoma	0.00289	0.00289	CcSEcCtD
Sevelamer—Pruritus—Epirubicin—sarcoma	0.00285	0.00285	CcSEcCtD
Sevelamer—Diarrhoea—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Sevelamer—Asthenia—Doxorubicin—sarcoma	0.00267	0.00267	CcSEcCtD
Sevelamer—Pruritus—Doxorubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Sevelamer—Vomiting—Epirubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Sevelamer—Diarrhoea—Doxorubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Sevelamer—Rash—Epirubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Sevelamer—Dermatitis—Epirubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Sevelamer—Nausea—Epirubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Sevelamer—Vomiting—Doxorubicin—sarcoma	0.00237	0.00237	CcSEcCtD
Sevelamer—Rash—Doxorubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Sevelamer—Dermatitis—Doxorubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Sevelamer—Nausea—Doxorubicin—sarcoma	0.00221	0.00221	CcSEcCtD
